Unique ID issued by UMIN | UMIN000031422 |
---|---|
Receipt number | R000035871 |
Scientific Title | SNP analysis of brexpiprazole-treated Japanese schizophrenia patients. |
Date of disclosure of the study information | 2018/02/26 |
Last modified on | 2021/03/08 11:32:03 |
SNP analysis of brexpiprazole-treated Japanese schizophrenia patients.
Genomics analysis-schizophrenia
SNP analysis of brexpiprazole-treated Japanese schizophrenia patients.
Genomics analysis-schizophrenia
Japan |
Schizophrenia
Psychiatry |
Others
YES
To explore factors associated with drug response in Japanese patients with schizophrenia based on information in clinical evaluation index and genetic information collected from those patients who have attended a clinical trial(Clinical Trials. gov, NCT01451164, #331-10-002).
Efficacy
Factors which influence antipsychotics responses will be explored.
Others,meta-analysis etc
18 | years-old | <= |
65 | years-old | > |
Male and Female
-Patients age 18 years or older to less than 65 years (at time of informed consent) diagnosed with schizophrenia based on DSM-IV-TR diagnostic criteria
-Patients who are hospitalized, or judged to required hospitalization, for acute relapse of schizophrenia at time of informed consent
-Patients who are experiencing acute exacerbation of psychotic symptoms
-Female patients who are breastfeeding or who have a positive pregnancy test (urine) result prior to receiving investigational medicinal product
-Patients presenting a first episode of schizophrenia based on the clinical judgement of the investigator
-Patients who are diagnosed with a disease other than schizophrenia (schizoaffective disorder, major depressive disorder, bipolar disorder, posttraumatic stress disorder, anxiety disorder, delirium, dementia, amnesia, or other cognitive disorder) based on current DSM-IV-TR Axis I criteria, or who are diagnosed with a personality disorder (borderline, paranoid, histrionic, schizotypal, schizoid, or antisocial)
280
1st name | |
Middle name | |
Last name | Hiroko Komatsu |
Otsuka Pharmaceutical, Co., Ltd
New Drug Research Division
Kagasuno 463-10, kawauchi-cho, Tokushima-shi, Tokushima 771-0192
088-665-2126
Komatsu.Hiroko@otsuka.jp
1st name | |
Middle name | |
Last name | Hiroko Komatsu |
Otsuka Pharmaceutical, Co., Ltd
New Drug Research Division
Kagasuno 463-10, kawauchi-cho, Tokushima-shi, Tokushima 771-0192
088-665-2126
Komatsu.Hiroko@otsuka.jp
Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.
Profit organization
NO
2018 | Year | 02 | Month | 26 | Day |
Unpublished
Completed
2017 | Year | 09 | Month | 05 | Day |
2017 | Year | 03 | Month | 14 | Day |
2018 | Year | 02 | Month | 19 | Day |
2021 | Year | 03 | Month | 31 | Day |
2021 | Year | 03 | Month | 31 | Day |
2021 | Year | 03 | Month | 31 | Day |
2021 | Year | 03 | Month | 31 | Day |
Exploration of factors associated with drug response in patients with schizophrenia based on information in clinical evaluation index and genetic information collected from those patients who have attended a clinical trial for Brexpiprazole.
2018 | Year | 02 | Month | 22 | Day |
2021 | Year | 03 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035871
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |